(Press-News.org) In a study that included more than 20,000 adults in China with high blood pressure but without a history of stroke or heart attack, the combined use of the hypertension medication enalapril and folic acid, compared with enalapril alone, significantly reduced the risk of first stroke, according to a study appearing in JAMA. The study is being released to coincide with its presentation at the American College of Cardiology Annual Scientific Session.
Stroke is the leading cause of death in China and second leading cause of death in the world. Primary prevention (prevention prior to a first episode) is particularly important because about 77 percent of strokes are first events. Uncertainty remains regarding the efficacy of folic acid therapy for primary prevention of stroke because of limited and inconsistent data, according to background information in the article.
Yong Huo, M.D., of Peking University First Hospital, Beijing, China, and colleagues had 20,702 adults with hypertension without history of stroke or heart attack randomly assigned to receive daily treatment with a single-pill combination containing enalapril (10 mg) and folic acid (0.8 mg; n = 10,348), or a tablet containing enalapril alone (10 mg; n = 10,354). The trial was conducted from May 2008 to August 2013 in 32 communities in Jiangsu and Anhui provinces in China. Participants were tested for variations in the MTHFR C677T gene (CC, CT, and TT genotypes) that may affect folate levels.
During a median treatment duration of 4.5 years, first stroke occurred in 282 participants (2.7 percent) in the enalapril-folic acid group compared with 355 participants (3.4 percent) in the enalapril group, representing an absolute risk reduction of 0.7 percent and a relative risk reduction of 21 percent. Analyses also showed significant reductions among participants in the enalapril-folic acid group in the risk of ischemic stroke (2.2 percent vs 2.8 percent) and composite cardiovascular events (cardiovascular death, heart attack and stroke) (3.1 percent vs 3.9 percent).
There was no significant difference between groups in the risk of hemorrhagic stroke, heart attack, or all-cause death, or in the frequencies of adverse events.
The authors write that this trial (China Stroke Primary Prevention Trial; CSPPT), with data on individual baseline folate levels and MTHFR genotypes, has provided convincing evidence that baseline folate level is an important determinant of efficacy of folic acid therapy in stroke prevention. "The CSPPT is the first large-scale randomized trial to test the hypothesis using individual measures of baseline folate levels. In this population without folic acid fortification, we observed considerable individual variation in plasma folate levels and clearly showed that the beneficial effect appeared to be more pronounced in participants with lower folate levels."
"We speculate that even in countries with folic acid fortification and widespread use of folic acid supplements such as in the United States and Canada, there may still be room to further reduce stroke incidence using more targeted folic acid therapy--in particular, among those with the TT genotype and low or moderate folate levels."
(doi:10.1001/jama.2015.2274; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Folate Supplements for Stroke Prevention
"The trial by Huo et al has important implications for stroke prevention worldwide," write Meir Stampfer, M.D., Dr.P.H., and Walter Willett, M.D., Dr.P.H., of the Harvard T. H. Chan School of Public Health and Channing Division of Network Medicine, Boston, in an accompanying editorial.
"Although the trial participants all had hypertension, there is little reason to doubt that the results would apply to normotensive persons, although the absolute effect would be smaller. It is possible to debate the ethics of whether a replication trial should be performed, especially because folic acid supplementation (or fortification) is safe and inexpensive, and carries other benefits. Large segments of the world's population, potentially billions of people, including those living in northern China, Bangladesh, and Scandinavia, have low levels of folate."
"Individuals with the TT genotype might particularly benefit, although it seems unlikely that genotyping for that purpose would be cost-effective. Also, some persons in the United States on the low end of the distribution of folate intake may benefit; effects in this subgroup would not have been detected in previous trials. Ideally, adequate folate levels would be achieved from food sources such as vegetables (especially dark green leafy vegetables), fruits and fruit juices, nuts, beans, and peas. However, for many populations, achieving adequate levels from diet alone is difficult because of expense or availability. This study seems to support fortification programs where feasible, and supplementation should be considered where fortification will take more time to implement."
(doi:10.1001/jama.2015.1961; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.
INFORMATION:
Boston, Mass., USA - Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Olivier Duverger, National Institutes of Health-National Institute of Neurological Disorders and Stroke, Bethesda, Md., USA, will present a study titled "Hair Keratins as Structural Organic Components of Mature Enamel: The Link Between Hair Disorders and Susceptibility to Dental Caries." The IADR General Session is being held in conjunction with the 44th Annual Meeting of the American Association for Dental Research and the 39th Annual Meeting ...
Estoril, Portugal: Researchers in the UK have, for the first time, shown how exhaust pollution from diesel engines is able to affect nerves within the lung. Air pollution is a significant threat to health, they say, and identifying potential mechanisms linking exposure to diesel exhaust and the exacerbation of respiratory diseases may lead to treatments for those affected.
Mr. Ryan Robinson, a PhD student at the National Heart and Lung Institute, Imperial College London, UK, will tell the 13th European Respiratory Society Lung Science Conference today (Saturday) about ...
BUILDINGS -- Shielding against energy loss ...
Air seeping from buildings is responsible for a large amount of wasted energy each year. To combat the problem, researchers at Oak Ridge National Laboratory collaborated with the Dow Chemical Company to develop a sprayable liquid flashing that is more cost-effective than traditional sealing materials such as peel-and-stick tapes. The new technology can be used in residential and commercial construction, and its ease of use results in increased energy savings and decreased labor and installation costs. Additionally, the liquid ...
COLUMBUS, OHIO and FORT WASHINGTON, PA -- Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in 2015, nearly 171,000 of the estimated 589,430 cancer deaths in the United States--more than 25 percent--will be caused by tobacco smoking.
To meet the needs of patients who are smokers at the time of a cancer diagnosis, the National Comprehensive Cancer Network® (NCCN®) has published the NCCN Clinical ...
A work group of physicians from leading academic medical centers across the country, including NYU Langone Medical Center, has developed new quality measures for the detection and treatment of childhood obstructive sleep apnea (OSA), a potentially morbid, life-altering condition that affects hundreds of thousands of children and adolescents nationwide. The measures, commissioned and endorsed by the American Association of Sleep Medicine (AASM), are published on March 15 in a special section of The Journal of Clinical Sleep Medicine.
Several different practice guidelines ...
DARIEN, IL - Today the American Academy of Sleep Medicine (AASM) published new quality measures for five common sleep disorders, which represents a landmark achievement in the promotion of high quality, patient-centered care in the medical subspecialty of sleep medicine.
The summary paper, "Measurement of Quality to Improve Care in Sleep Medicine," is published in the March issue of the Journal of Clinical Sleep Medicine along with five workgroup papers presenting outcome and process measures to aid in evaluating the quality of care of restless legs syndrome, insomnia, ...
TORONTO, March 13, 2015 - York University researchers have learned how living beings can keep gene expression in check -- which might partly explain the uncontrolled gene expression found in many cancers.
"Using yeast as a model organism, we studied the Tup1 protein, a negative regulator of gene expression," says Biology Professor Emanuel Rosonina, adding, "This protein binds to some genes and blocks their expression, helping to ensure genes that shouldn't be turned on remain inactive."
The current study, jointly conducted by York University and Columbia University ...
New York, NY--March 23, 2015--A team of Columbia Engineering researchers has invented a technology--full-duplex radio integrated circuits (ICs)--that can be implemented in nanoscale CMOS to enable simultaneous transmission and reception at the same frequency in a wireless radio. Up to now, this has been thought to be impossible: transmitters and receivers either work at different times or at the same time but at different frequencies. The Columbia team, led by Electrical Engineering Associate Professor Harish Krishnaswamy, is the first to demonstrate an IC that can accomplish ...
Following a successful launch at 10:44 p.m. EDT Thursday, NASA's four Magnetospheric Multiscale (MMS) spacecraft are positioned in Earth's orbit to begin the first space mission dedicated to the study of a phenomenon called magnetic reconnection. This process is thought to be the catalyst for some of the most powerful explosions in our solar system.
The spacecraft, positioned one on top of the other on a United Launch Alliance Atlas V 421 rocket, launched from Cape Canaveral Air Force Station, Florida. After reaching orbit, each spacecraft deployed from the rocket's upper ...
Tropical Cyclone Nathan has made its cyclonic loop in the Coral Sea near Queensland, Australia's Cape York Peninsula, and is headed away from land. However, satellite imagery reveals that Nathan's movement away from Queensland is a slow crawl.
On March 13 at 1500 UTC (11 a.m. EDT), Tropical Cyclone Nathan's maximum sustained winds were near 55 knots (63 mph/102 kph). It was centered near 13.1 south latitude and 145.5 east longitude, about 229 nautical miles (263 miles/424 kph) north of Cairns, Australia. Nathan has slowed down and was moving to the east-northeast at 2 ...
